SEC Form 4 · accession 0000920465-19-000011
LA JOLLA PHARMACEUTICAL CO · LJPC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
George F Tidmarsh
Officer — President, CEO & Secretary · Director
Period of report
Jan 7, 2019
Accepted (ET)
Jan 9, 2019 · 9:29 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000920465
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 7, 2019 | P | 82 | $5.85 | A | 1,281,408 | D | |
| Common Stock | Jan 7, 2019 | P | 287 | $5.85 | A | 1,281,695 | D | |
| Common Stock | Jan 7, 2019 | P | 98 | $5.85 | A | 1,281,793 | D | |
| Common Stock | Jan 7, 2019 | P | 397 | $5.85 | A | 1,282,190 | D | |
| Common Stock | Jan 7, 2019 | P | 700 | $5.85 | A | 1,282,890 | D | |
| Common Stock | Jan 7, 2019 | P | 436 | $5.85 | A | 1,283,326 | D | |
| Common Stock | holding | — | — | — | 22,000 | I | By children |
Table II — derivative securities
No Table II lines on this filing.